Evidence-Based Medicine Guidelines
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Early Versus Deferred Androgen Suppression in the Treatment of Advanced Prostatic Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/450615/all/Early_versus_deferred_androgen_suppression_in_the_treatment_of_advanced_prostatic_cancer.
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/450615/all/Early_versus_deferred_androgen_suppression_in_the_treatment_of_advanced_prostatic_cancer. Accessed May 19, 2025.
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/450615/all/Early_versus_deferred_androgen_suppression_in_the_treatment_of_advanced_prostatic_cancer
Early Versus Deferred Androgen Suppression in the Treatment of Advanced Prostatic Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 19]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/450615/all/Early_versus_deferred_androgen_suppression_in_the_treatment_of_advanced_prostatic_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Early versus deferred androgen suppression in the treatment of advanced prostatic cancer
ID - 450615
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/450615/all/Early_versus_deferred_androgen_suppression_in_the_treatment_of_advanced_prostatic_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
